Sun Pharmaceutical Industries Limited
SUNPHARMA
Peringkat dalam Saham
#525
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Harga Saham
$19.24
Kapitalisasi Pasar
$46.15B
Perubahan (1 hari)
-0.97%
Perubahan (1 tahun)
0.84%
Negara
IN
Perdagangan Sun Pharmaceutical Industries Limited (SUNPHARMA)
Kategori
Healthcare
EPS untuk Sun Pharmaceutical Industries Limited (SUNPHARMA)
EPS per June 2026 TTM: $0.56
Menurut laporan keuangan terbaru dan harga saham Sun Pharmaceutical Industries Limited, EPS perusahaan saat ini (TTM) adalah $0.56. Pada akhir 2024, perusahaan memiliki EPS sebesar $0.48 peningkatan dibandingkan EPS tahun 2023 sebesar $0.43.
Riwayat EPS untuk Sun Pharmaceutical Industries Limited dari 2004 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.56 | 4.96% |
| 2025 | $0.53 | 11.41% |
| 2024 | $0.48 | 11.35% |
| 2023 | $0.43 | 139.18% |
| 2022 | $0.18 | 8.71% |
| 2021 | $0.17 | -20.64% |
| 2020 | $0.21 | 30.19% |
| 2019 | $0.16 | 15.61% |
| 2018 | $0.14 | -69.05% |
| 2017 | $0.45 | 56.75% |
| 2016 | $0.29 | -5.81% |
| 2015 | $0.30 | 19.44% |
| 2014 | $0.25 | -4.30% |
| 2013 | $0.27 | 4.58% |
| 2012 | $0.25 | 29.09% |
| 2011 | $0.20 | 35.66% |
| 2010 | $0.14 | -16.31% |
| 2009 | $0.17 | -7.39% |
| 2008 | $0.19 | 94.07% |
| 2007 | $0.10 | 38.62% |
| 2006 | $0.07 | 41.63% |
| 2005 | $0.05 | 19.51% |
| 2004 | $0.04 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CH
|
